Abiopharma

🔍 Crocker Mary Jayne (Executive)

Company: Bridgewater Bancshares Inc (BWB)

Report Date: 2026-04-16

Detailed Transactions and Holdings:

• Acquired 6,750 shares of Common Stock at $12.92 per share (Direct)
  Date: 2026-04-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 216,027.00 | transaction_form_type: 4
• Sold 6,750 shares of Option to buy at $12.92 per share (Derivative)
  Date: 2026-04-16 | Code: M | Expires: 2029-12-06 | equity_swap_involved: 0 | shares_owned_after: 20,250.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 91,102 shares of Option to buy at $7.47 per share (Derivative)
  Date: 2026-04-16 | Code: H | Expires: 2027-09-30 | shares_owned_after: 91,102.00 | Footnotes: F1, F3
• Holds 20,000 shares of Option to buy at $17.5 per share (Derivative)
  Date: 2026-04-16 | Code: H | Expires: 2032-02-01 | shares_owned_after: 20,000.00 | Footnotes: F1, F4

Footnotes:

• F1: Options to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Option Plan.
• F2: Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 12/6/2019.
• F3: Options exercisable in 20% increments on the first five anniversaries of the date of the grant which was 10/1/2017.
• F4: Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 2/1/2022.